×
验证码:
换一张
忘记密码?
记住我
切换中国科技网通行证登录
×
切换中国科技网通行证登录
登录
中文版
|
English
中国科学院合肥物质科学研究院机构知识库
Knowledge Management System of Hefei Institute of Physical Science,CAS
登录
注册
ALL
ORCID
题名
作者
学科领域
关键词
文献类型
出处
收录类别
出版者
发表日期
存缴日期
资助项目
学科门类
学习讨论厅
图片搜索
粘贴图片网址
首页
研究单元&专题
作者
文献类型
学科分类
知识图谱
新闻&公告
在结果中检索
研究单元&专题
中科院强磁场科学中心 [4]
合肥创新院 [1]
作者
刘青松 [14]
王傲莉 [11]
王文超 [9]
胡晨 [9]
吴宏 [5]
亓爽 [4]
更多...
发表日期
2022 [3]
2021 [4]
2020 [3]
2019 [2]
2018 [2]
语种
英语 [14]
出处
EUROPEAN J... [4]
ACTA PHARM... [3]
SIGNAL TRA... [3]
CANCER LET... [1]
EUROPEAN J... [1]
INTERNATIO... [1]
更多...
资助项目
Frontier ... [14]
CASHIPS Di... [7]
National N... [7]
National N... [6]
Natural Sc... [6]
China Post... [5]
更多...
资助机构
Frontier ... [14]
National ... [14]
Natural S... [14]
China Pos... [10]
CASHIPS Di... [9]
Youth Inno... [6]
更多...
收录类别
SCI [14]
摘要
文献类型
期刊论文 [14]
×
知识图谱
HFCAS OpenIR
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共14条,第1-10条
帮助
限定条件
资助机构:Natural Science Foundation of Anhui Province
资助项目:Frontier Science Key Research Program of CAS[QYZDB-SSW-SLH037]
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
WOS被引频次升序
WOS被引频次降序
题名升序
题名降序
发表日期升序
发表日期降序
作者升序
作者降序
期刊影响因子升序
期刊影响因子降序
提交时间升序
提交时间降序
Discovery of Pyrrolo[2,3-d]pyrimidine derivatives as potent and selective colony stimulating factor 1 receptor kinase inhibitors
期刊论文
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 卷号: 243
作者:
Liang, Xiaofei
;
Wang, Chun
;
Wang, Beilei
;
Liu, Juan
;
Qi, Shuang
;
Wang, Aoli
;
Liu, Qingwang
;
Deng, Maoqing
;
Wang, Li
;
Liu, Jing
;
Liu, Qingsong
收藏
  |  
浏览/下载:38/0
  |  
提交时间:2022/12/23
CSF1R inhibitor
Kinase inhibitor
Macrophage polarization
Repurposing of the FGFR inhibitor AZD4547 as a potent inhibitor of necroptosis by selectively targeting RIPK1
期刊论文
ACTA PHARMACOLOGICA SINICA, 2022
作者:
Wang, Zuo-wei
;
Zou, Feng-ming
;
Wang, Ao-li
;
Yang, Jing
;
Jin, Rui
;
Wang, Bei-lei
;
Shen, Li-juan
;
Qi, Shuang
;
Liu, Juan
;
Liu, Jing
;
Wang, Wen-chao
;
Liu, Qing-song
收藏
  |  
浏览/下载:39/0
  |  
提交时间:2022/12/22
AZD4547
RIPK1
inhibitors
SIRS model
anti-necroptosis
CHMFL-26 is a highly potent irreversible HER2 inhibitor for use in the treatment of HER2-positive and HER2-mutant cancers
期刊论文
ACTA PHARMACOLOGICA SINICA, 2022
作者:
Cao, Jiang-yan
;
Qi, Shuang
;
Wu, Hong
;
Wang, Ao-li
;
Liu, Qing-wang
;
Li, Xi-xiang
;
Wang, Bei-lei
;
Ge, Juan
;
Zou, Feng-ming
;
Chen, Cheng
;
Wang, Jun-jie
;
Hu, Chen
;
Liu, Jing
;
Wang, Wen-chao
;
Liu, Qing-song
收藏
  |  
浏览/下载:86/0
  |  
提交时间:2022/03/28
HER2
breast cancers
gastric cancers
irreversible inhibitor
drug resistance
An overview of kinase downregulators and recent advances in discovery approaches
期刊论文
SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2021, 卷号: 6
作者:
Wang, Beilei
;
Wu, Hong
;
Hu, Chen
;
Wang, Haizhen
;
Liu, Jing
;
Wang, Wenchao
;
Liu, Qingsong
收藏
  |  
浏览/下载:68/0
  |  
提交时间:2022/01/25
Targeting chaperon protein HSP70 as a novel therapeutic strategy for FLT3-ITD-positive acute myeloid leukemia
期刊论文
SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2021, 卷号: 6
作者:
Hu, Chen
;
Zou, Fengming
;
Wang, Aoli
;
Miao, Weili
;
Liang, Qianmao
;
Weisberg, Ellen L.
;
Wang, Yinsheng
;
Liu, Jing
;
Wang, Wenchao
;
Liu, Qingsong
收藏
  |  
浏览/下载:52/0
  |  
提交时间:2021/11/01
Discovery of a highly potent kinase inhibitor capable of overcoming multiple imatinib-resistant ABL mutants for chronic myeloid leukemia (CML)
期刊论文
EUROPEAN JOURNAL OF PHARMACOLOGY, 2021, 卷号: 897
作者:
Lu, Tingting
;
Cao, Jiangyan
;
Zou, Fengming
;
Li, Xixiang
;
Wang, Aoli
;
Wang, Wenliang
;
Liang, Huamin
;
Liu, Qingwang
;
Hu, Chen
;
Chen, Cheng
;
Hu, Zhenquan
;
Wang, Wenchao
;
Li, Lili
;
Ge, Jian
;
Shen, Yang
;
Ren, Tao
;
Liu, Jing
;
Xia, Ruixiang
;
Liu, Qingsong
收藏
  |  
浏览/下载:61/0
  |  
提交时间:2021/04/26
BCR-ABL
ABL mutants
Chronic myeloid leukemia
Kinase inhibitor
Imatinib resistance
Nanocrystal-loaded liposome for targeted delivery of poorly water-soluble antitumor drugs with high drug loading and stability towards efficient cancer therapy
期刊论文
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2021, 卷号: 599
作者:
Liang, Huamin
;
Zou, Fengming
;
Liu, Qingwang
;
Wang, Beilei
;
Fu, Liyi
;
Liang, Xiaofei
;
Liu, Jing
;
Liu, Qingsong
收藏
  |  
浏览/下载:46/0
  |  
提交时间:2021/05/17
Liposome
Drug nanocrystal
Core-shell
Drug delivery
Tumor therapy
BCR-ABL
Discovery of a highly potent and selective Bruton's tyrosine kinase inhibitor avoiding impairment of ADCC effects for B-cell non-Hodgkin lymphoma
期刊论文
SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2020, 卷号: 5
作者:
Liu, Juan
;
Liang, Qianmao
;
Wang, Aoli
;
Zou, Fengming
;
Qi, Ziping
;
Yu, Kailin
;
Liu, Qingwang
;
Chen, Cheng
;
Liu, Jing
;
Liu, Qingsong
收藏
  |  
浏览/下载:46/0
  |  
提交时间:2020/11/30
Pharmacologically inhibiting phosphoglycerate kinase 1 for glioma with NG52
期刊论文
ACTA PHARMACOLOGICA SINICA, 2020
作者:
Wang, Wen-liang
;
Jiang, Zong-ru
;
Hu, Chen
;
Chen, Cheng
;
Hu, Zhen-quan
;
Wang, Ao-li
;
Wang, Li
;
Liu, Jing
;
Wang, Wen-chao
;
Liu, Qing-song
收藏
  |  
浏览/下载:56/0
  |  
提交时间:2020/11/26
PGK1
NG52
kinase inhibitor
Warburg effect
glioma
Discovery of 6 '-chloro-N-methyl-5 '-(phenylsulfonamido)-[3,3 '-bipyridine]-5-carboxamide (CHMFL-PI4K-127) as a novel Plasmodium falciparum PI(4)K inhibitor with potent antimalarial activity against both blood and liver stages of Plasmodium
期刊论文
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 卷号: 188
作者:
Liang, Xiaofei
;
Jiang, Zongru
;
Huang, Zhenghui
;
Li, Feng
;
Chen, Cheng
;
Hu, Chen
;
Wang, Wenliang
;
Hu, Zhenquan
;
Liu, Qingwang
;
Wang, Beilei
;
Wang, Li
;
Qi, Ziping
;
Liu, Jing
;
Jiang, Lubin
;
Liu, Qingsong
收藏
  |  
浏览/下载:53/0
  |  
提交时间:2020/11/26
PI4K kinase
Kinase inhibitor
Malaria
Blood stage
Liver stage